VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Inderal
Preclinical
Small molecule
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Craving
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Craving
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Craving
1 trial
Reducing Drug Craving Memories
Unknown status
·
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
·
N/A
·
NCT01319214
·
60 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Inderal. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Inderal compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Inderal. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
McGill University Health Centre/Research Institute of the McGill University Health Centre company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
Related News